Obesity: A Disease

In this episode, we will be hearing from Dr. Suzanne Cuda, President and Medical Director for Alamo City Healthy Kids and Families. Joining her is Nancy Browne and Dr. Valarie O’Hara. Nancy is a nurse practitioner, pediatric obesity medicine specialist and is also a co-author of the OMA Pediatric Obesity Clinical Practice Statements. Dr. O’Hara is an ABOM certified obesity specialist and the medical director of the WOW 4 Wellness Clinic. Today’s topics are foundational therapies, shared decision making, off-label treatment and pharmacotherapy treatment options in pediatrics. Episode Guests Dr. Suzanne Cuda Nancy Browne Dr. Valarie O’Hara Related Resources Pediatric Obesity Algorithm® OMA Pediatric Resources Webpage OMA Blog

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org. In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Dr. Shagun Bindlish, MD Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars®

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Robert Lustig, discuss non-alcoholic fatty liver disease and obesity. Dr. Lustig is a professor of pediatric in the division of endocrinology at UCSF. In addition to his rich contribution to the medical literature, he is an author of several best-selling books, and a passionate advocate for promoting metabolic health and nutrition especially with respect to the health risks of sugar. He was the keynote speaker at the OMA’s 2022 Fall Obesity Summit. His presentation was titled ” The BIG Picture: NAFLD, the sentinel disease of metabolic syndrome”. Topics discussed include the health consequences of sugar consumption, the prevalence of NAFLD, diagnosing NAFLD, and treatment through medication, nutrition, and weight loss. Episode Guests Dr. Nick Pennings, DO, FOMA Dr. Robert Lustig, MD Resources Mentioned Fat Chance and Metabolical, by Dr. Lustig Related Resources Overcoming Obesity Conference Obesity Algorithm® Obesity Medicine Association Blog

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. In this three part series, Dr. Bays and Dr. Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Tiffany Lowe-Clayton, DO Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars Journal

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Andreas Acosta discuss the importance of aligning appropriate lifestyle interventions to each of the four key phenotypes that explain about eighty-five percent of patients with obesity. Andreas Acosta, MD, PhD is an assistant professor in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, MN. Dr. Acosta presented his exciting research at the OMA Fall 2022 Obesity Summit in Anaheim, CA, in a presentation titled “Phenotype-Guided Lifestyle Intervention for Obesity Management" Topics discussed include hungry gut, emotional eater, and slow metabolizer phenotypes. Additional topics include overlapping phenotypes, phenotype profiling, and treatment approaches. Episode Guests Andreas Acosta, MD, PhD Nicholas Pennings, DO, FOMA, FACOFP

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. In this three part series, Dr. Bays and Dr. Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Tiffany Lowe-Clayton, DO Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars Journal

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Nicholas Pennings, DO, FOMA, FACOFP, and John Jakicic, PhD, discuss the importance of physical activity in weight management and overall health. Dr. John Jakicic is a Research Professor in the Department of Internal Medicine in the Division of Physical Activity and Weight Management at the University of Kansas. Dr. Jakicic presented at the OMA Fall 2022 Obesity Summit in Anaheim, CA. His talk was titled “Weight a Minute: Considerations for Physical Activity Being Effective for Weight Loss and Maintenance”. Topics discussed include the expectations of the benefits of exercise, the role of physical activity in obesity treatment, pairing dietary recommendations with physical activity plans, and adaptive mechanisms. Episode Guests Nicholas Pennings, DO, FOMA, FACOFP John Jakicic, PhD

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings is joined by Karen Herbst, MD, PhD, a board certified endocrinologist who serves as the Medical and Research Director for Total Lipedema Care in Beverly Hills, CA. In this podcast, Dr. Pennings discusses recognizing and treating lipedema with Dr. Herbst. Today's topics include a description of lipedema, distinguishing characteristics of the condition, evaluating patients with lipedema, distinguishing lymphedema from lipedema, the emotional toll of lipedema on patients, the US Standards of Care for Lipedema, management of the condition, and treatment options. Episode Guests Karen Herbst, MD, PhD Nicholas Pennings, DO, FOMA Resources Mentioned US Standards of Care for Lipedema Total Lipedema Care Lipomadoc Related Resources Emerging from the Shadows, Recognizing and Treating Lipedema

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org. In this three part series, Dr. Bays and Dr. Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Tiffany Lowe-Clayton, DO Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars Journal

Leading cardiovascular researcher, D.r Carl "Chip" Lavie, has made many contributions to understanding and improving cardiovascular health including identifying the obesity paradox. Patients with obesity whom have had a major adverse cardiovascular event are expected to have worse outcomes than their normal weight counterparts. However, people with obesity have statistically better outcomes than normal weight individuals with cardiovascular disease. This is referred to as the obesity paradox. In this podcast, OMA Executive Director of Clinical Education Dr. Nicholas Pennings interviews Dr. Lavie discussing the obesity paradox and the many variables that influence the obesity paradox including the severity of obesity, body fat distribution, and the role of physical activity on cardiovascular outcomes in patients with obesity. Episode Guests Carl "Chip" Lavie, MD Nick Pennings, DO, FOMA Related Resources Obesity Pillars Journal Obesity Medicine 2023 Conference "Obesity and Obesity Paradox and Cardiovascular Disease"